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Abstract  
Severe malaria in neonates is a rare occurrence because of the protective effect of fetal haemoglobin and passively acquired maternal antibodies. 
Despite this protection, severe malaria can still occur and may be confused with neonatal sepsis due to an overlap of clinical manifestations. 
Therefore, febrile neonates in malaria endemic region should be routinely screened for malaria because any delay in making a diagnosis and 
instituting adequate and effective treatment can lead to the death of the neonate. This is the first clinical report and successful use of parenteral 
artesunate for treatment of severe malaria in a Nigerian neonate that is documented in literature to the best of our knowledge. 
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Malaria has been documented as a leading cause of infant morbidity 
and mortality in Africans [1]. Nonetheless, infants appear to be 
relatively protected from clinical malaria, and from the severe 
consequences of malaria infection, for the first 3-6 months of life 
because of the preponderance of fetal haemoglobin in their red 
blood corpuscles, which are relatively resistant to penetration by the 
malarial parasite [2,3]. Furthermore, maternal antibodies also 
protect infants in the first 3 months of life [2]. Therefore, severe 
malaria is an unusual occurrence in children below 3 months of age 
especially neonates. However, this protection from malaria is not 
absolute and the protective mechanisms can be overwhelmed by 
very high transmission intensities [4]. Severe malaria is a life-
threatening medical emergency and requires institution of prompt 
and effective treatment to avert death. The rarity of severe malaria 
in neonates is buttressed by the fact that standardized management 
guidelines are not readily available for this age group. We hereby 
report an unusual case of severe malaria in a Nigerian neonate as 
well as highlight challenges in the management of such cases in a 
resource constrained setting.  
  
  
Patient and observation 
 
NC, a 25 day old male presented at the children outpatient clinic of 
Madonna University Elele , Niger Delta region of Nigeria, in company 
of parents with, a five day history of fever and reduced activity. The 
pregnancy history was unremarkable and the mother had no febrile 
illness during pregnancy. The child was on exclusive breastfeeding 
and his immunizations were up to date. The mother administered 
paracetamol and vitamin C prior to presentation. The child was 
brought to the hospital for expert care because his fever persisted 
despite self-medication. NC is the 3rd child in a monogamous family 
and both parents a attained primary level of education. NC lives in 
an apartment and he does not sleep under an insecticide-treated 
net. A diagnosis of presumed late-onset neonatal sepsis was made 
and the baby was admitted to the children ward for investigation 
and treatment. However, the parents initially declined admission on 
grounds of financial constraint and opted to seek alternative care 
elsewhere. About 18 hours later, they presented again at the 
children emergency department with worsening of the child's 
condition. The patient had developed difficulty with breathing and 
had become weaker. On examination, the child's weight was 3.8 kg, 
he was febrile (38.50C); Pulse rate 140 / min; Respiratory 
rate,70/minute. He was moderately pale, anicteric, acyanotic and 
not dehydrated. Anterior fontanelle was patent and slightly 
depressed; muscle tone was normal and primitive reflexes were 
present and intact. The Liver was palpable 4 cm beneath right costal 
margin and was tender. The Spleen was tipped. Available laboratory 
results showed: Numerous trophozoites of Plasmodium falciparum, 
Haemoglobin of 7g/dl, WBC 10,700/mm3, Neutrophils 36%, 
lymphocytes 48% and monocytes 16%. Random blood sugar was 
80mg/dl and urinalysis was normal. Blood culture could not be done 
due to lack of funds. A diagnosis of severe malaria with severe 
anaemia in anaemic heart failure was made with late-onset sepsis 
as a differential diagnosis. The patient was transfused with 
sedemented cells and was given intravenous furosemide stat 
alongside. He was also commenced on intravenous artesunate 
2.4mg/kg/dose given at 0, 12, 24, and 48 hours, and later changed 
to oral artemeter- lumefantrin (20mg/120mg) combination one 
tablet twice daily for three days. He was also placed on I.V 
ceftriazone 50mg/kg daily for five days. He was discharged home 
after five days of admission in a stable condition and the parents 
were advised to get an insecticide-treated net for use. The child is 
currently on follow-up on an outpatient basis and is asymptomatic 





Severe malaria usually occurs as a result of a delay in instituting 
effective and adequate treatment of uncomplicated malaria caused 
by Plasmodium falciparum [5]. The delay in seeking early medical 
attention by the parents of NC may have played a contributory role 
in the progression to severe malaria. Unless parasitemia is severe, 
clinical malaria is a rare occurrence in neonates because of the 
presence of passive maternal antibodies and fetal haemoglobin 
[2,3]. Additionally, most nursing mothers stay indoors with their 
babies, wear protective clothing on their babies and lay them under 
bed nets. These measures drastically reduce the chances of a 
mosquito biting a child. Baby NC may have acquired malaria 
because parents neither owned nor used insecticide treated nets. 
This was not surprising because of the low socioeconomic status of 
the parents. Furthermore, NC had severe parasitemia, and this 
could explain why he developed severe malaria despite the 
protection from maternal antibodies and fetal haemoglobin. No 
standardized management guidelines are currently available for 
treatment of severe malaria in neonates. Parenteral artesunate was 
preferred over parenteral quinine because of the World health 
organization (WHO) recommendation that intravenous artesunate 
should be used in preference to quinine for the treatment of severe 
P. falciparum malaria in children [5]. This was based on the 
observation that intravenous or intramuscular artesunate has been 
shown to significantly reduce the risk of death in children from 
severe malaria compared to intravenous quinine [5]. Additionally, 
intravenous artesunate offers a number of advantages over 
intravenous quinine in terms of not requiring rate-controlled infusion 
or cardiac monitoring [5]. Concurrent parenteral antibiotics were 
used, though blood culture was not done and the full blood count 
result of the patient did not show evidence of bacterial infection. 
The routine use of antibiotics in severe malaria is controversial. It is 
noteworthy that invasive bacterial infection is a recognized 
complication of Plasmodium falciparum malaria and may increase 
the case fatality substantially [6]. The signs and symptoms of 
malarial infection in neonates closely mimic neonatal sepsis. 
Therefore, a high index of suspicion is required to diagnose severe 
malaria in neonates. This can explain why presumed late onset 
neonatal sepsis was the initial diagnosis when patient presented to 
the hospital. The initial refusal of admission by the parents lead to a 
delay in instituting therapy for a life-threatening illness in the 
neonate. Also, difficulty by the parents in paying for some necessary 
investigations due to financial constraint brings to fore the issues 
with out-of-pocket spending for health services. It is pertinent to 
note that the National health insurance policy does not cover every 
citizen in Nigeria especially in the informal sector where these 





Though severe malaria is a rare occurrence in neonates, 
paediatricians caring for children in malaria endemic regions should 
routinely screen febrile neonates for malaria, because any delay in 
making a diagnosis and instituting adequate and effective treatment 
can lead to the death. We found I.V artesunate safe and effective in 
the treatment of severe malaria in a Nigerian neonate. There is 
need for further studies so that a standard protocol can be 
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developed for use in neonates. We recommend the use of I.V 
artesunate for the treatment of severe malaria in neonates. We 
advocate a free or subsidized health care service for children under 
five years of age especially and for neonates. Insecticide- treated 
nets should be made readily available and affordable for use in 
households. This will help in reducing unacceptably high neonatal 
deaths from malaria in Nigeria, which is a significant contributor to 
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